Dr Robert Christopher Call, MD | |
Bldg 50, Farenholt Street, Agana Hts, GU 96910 | |
(671) 344-9419 | |
Not Available |
Full Name | Dr Robert Christopher Call |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | Bldg 50, Farenholt Street, Agana Hts, Guam |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467688150 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 0101247927 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Christopher Call, MD Psc 455 Box 208, Fpo, AP 96540-0003 Ph: (671) 344-9419 | Dr Robert Christopher Call, MD Bldg 50, Farenholt Street, Agana Hts, GU 96910 Ph: (671) 344-9419 |
News Archive
In a new study issued by the American Enterprise Institute-Brookings Joint Center for Regulatory Studies, Prieger found that, while still at increased risk, drivers who use cell phones are less likely to have accidents by as much as 36 percent than previous studies predicted.
Research has shown convincing evidence that dietary patterns practiced during adulthood are important contributors to age-related cognitive decline and dementia risk.
About 200 epilepsy specialists, neurosurgeons and pediatric neurologists from around the nation and the world are registered to attend the Third International Epilepsy Colloquium in Cleveland from May 19 to 22. The conference is sponsored by the Neurological Institute at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
› Verified 7 days ago